Summary
A method is given for extraction and quantitative determination of imipramine (Tofranil®) and some of its metabolites in the brain tissue. The recovery of imipramine added to brain tissue/amount extracted from the brain was determined for imipramine, desmethylimipramine, didesmethylimipramine and iminodibenzyl.
The uptake and metabolism of imipramine in the rat brain were determined after administration of a single dose. The imipramine level in the brain reached a maximum one hour after i.p. administration, whereas after subcutaneous injection the maximum is only reached after 2 hours. In either case only 0.2% of the imipramine given is absorbed by the brain.
In none of the cases were metabolites of imipramine found after the short time tests.
In contrast to imipramine, desmethylimipramine (Pertofran®) is found in the rat brain only after a long period (4 hours).
No accumulation of the drug in the brain was observed after daily administration of imipramine for 10 days and under the test conditions mentioned. A level, amounting to 2 μg imipramine/brain, is reached as early as the first day of administration. Desmethylimipramine appeared for the first time on the third test day, and its level remained practically unchanged from the third to the tenth day at 1 μg/brain.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Bickel, M. H., and M. Baggiolini: The metabolism of imipramine and its metabolites by rat liver microsomes. Biochem. Pharmacol. 15, 1155–1169 (1966).
Cassano, G. B., and E. Hansson: Autoradiographic distribution studies in mice with C14-imipramine. Int. J. Neuropsychiat. 2, 269–278 (1966).
Crammer, J. L., and B. Scott: New metabolites of imipramine. Psychopharmacologia (Berl.) 8, 461–468 (1966).
Dingell, J. V., F. Sulser, and J. R. Gillette: Species differences in the metabolism of imipramine and desmethylimipramine (DMI). J. Pharmacol. exp. Ther. 143, 14–22 (1964).
Herrmann, B.: Quantitative Methoden zur Untersuchung des Stoffwechsels von Tofranil®. Helv. physiol. pharmacol. Acta 21, 402–408 (1963).
—, u. R. Pulver: Der Stoffwechsel des Psychopharmakons Tofranil. Arch. int. Pharmacodyn. 126, 454–469 (1960).
Michaelis, W., and G. Stille: Demethylation of imipramine and antitetrabenazine effect in the catalepsy and ptosis test. Life Sci. 7, 99–106 (1968).
Sachsse, W., u. G. Quadbeck: Psychopharmaka bei Daueranwendung im Tierversuch. Med. exp. (Basel) 5, 141–145 (1961).
Schneider, G.: Ein verbesserter Nachweis von Imipramin (Tofranil®) und einiger seiner Metaboliten auf Papier-Chromatogrammen. J. Chromatogr. 31, 612–614 (1967).
—: Verbesserte Methoden zum Nachweis und zur Bestimmung geringer Mengen von Imipramin (Tofranil) und einiger seiner Metaboliten. Z. analyt. Chem. 237, 38–49 (1968).
—, u. G. Schneider: Zur papierelektrophoretischen Trennung des Psychopharmakons Tofranil und einiger seiner Metaboliten. J. Chromatogr. 37, 348–349 (1968).
Author information
Authors and Affiliations
Additional information
Mit Unterstützung der Deutschen Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Schneider, G. Über die Aufnahme des Psychopharmakons Imipramin in das Rattenhirn und seinen Metabolismus bei einmaliger und bei chronischer Gabe des Medikamentes. Psychopharmacologia 14, 74–82 (1969). https://doi.org/10.1007/BF00401536
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00401536